68 related articles for article (PubMed ID: 22245509)
1. Imaging the post-treatment pelvis with gynecologic cancers.
Moradi B; Hejazian SS; Tahamtan M; Ghorani H; Karami S
Abdom Radiol (NY); 2024 Apr; 49(4):1248-1263. PubMed ID: 38340181
[TBL] [Abstract][Full Text] [Related]
2. Imaging biomarker roadmap for cancer studies.
O'Connor JP; Aboagye EO; Adams JE; Aerts HJ; Barrington SF; Beer AJ; Boellaard R; Bohndiek SE; Brady M; Brown G; Buckley DL; Chenevert TL; Clarke LP; Collette S; Cook GJ; deSouza NM; Dickson JC; Dive C; Evelhoch JL; Faivre-Finn C; Gallagher FA; Gilbert FJ; Gillies RJ; Goh V; Griffiths JR; Groves AM; Halligan S; Harris AL; Hawkes DJ; Hoekstra OS; Huang EP; Hutton BF; Jackson EF; Jayson GC; Jones A; Koh DM; Lacombe D; Lambin P; Lassau N; Leach MO; Lee TY; Leen EL; Lewis JS; Liu Y; Lythgoe MF; Manoharan P; Maxwell RJ; Miles KA; Morgan B; Morris S; Ng T; Padhani AR; Parker GJ; Partridge M; Pathak AP; Peet AC; Punwani S; Reynolds AR; Robinson SP; Shankar LK; Sharma RA; Soloviev D; Stroobants S; Sullivan DC; Taylor SA; Tofts PS; Tozer GM; van Herk M; Walker-Samuel S; Wason J; Williams KJ; Workman P; Yankeelov TE; Brindle KM; McShane LM; Jackson A; Waterton JC
Nat Rev Clin Oncol; 2017 Mar; 14(3):169-186. PubMed ID: 27725679
[TBL] [Abstract][Full Text] [Related]
3. Gynecologic tumor board: a radiologist's guide to vulvar and vaginal malignancies.
Chow L; Tsui BQ; Bahrami S; Masamed R; Memarzadeh S; Raman SS; Patel MK
Abdom Radiol (NY); 2021 Dec; 46(12):5669-5686. PubMed ID: 34435227
[TBL] [Abstract][Full Text] [Related]
4. Role of Positron Emission Tomography/Computed Tomography in Preoperative Assessment of Carcinoma Endometrium-a Retrospective Analysis.
Kulkarni R; Bhat RA; Dhakharia V; Kallur K; Gangoli A
Indian J Surg Oncol; 2019 Mar; 10(1):225-231. PubMed ID: 30948905
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.
Petersen H; Holdgaard PC; Madsen PH; Knudsen LM; Gad D; Gravergaard AE; Rohde M; Godballe C; Engelmann BE; Bech K; Teilmann-Jørgensen D; Mogensen O; Karstoft J; Johansen J; Christensen JB; Johansen A; Høilund-Carlsen PF;
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):695-706. PubMed ID: 26519292
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up.
Rusu D; Carlier T; Colombié M; Goulon D; Fleury V; Rousseau N; Berton-Rigaud D; Jaffre I; Kraeber-Bodéré F; Campion L; Rousseau C
Front Med (Lausanne); 2015; 2():46. PubMed ID: 26258124
[TBL] [Abstract][Full Text] [Related]
7. Gynecologic biopsy for molecular profiling: a review for the interventional radiologist.
Corr BR; Behbakht K; Spillman MA
Semin Intervent Radiol; 2013 Dec; 30(4):417-24. PubMed ID: 24436571
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
Bernsdorf M; Graff J
Clin Physiol Funct Imaging; 2014 Nov; 34(6):426-33. PubMed ID: 24267489
[TBL] [Abstract][Full Text] [Related]
9. Lymph node imaging in gynecologic malignancy.
Lai G; Rockall AG
Semin Ultrasound CT MR; 2010 Oct; 31(5):363-76. PubMed ID: 20974356
[TBL] [Abstract][Full Text] [Related]
10. PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
Dalla Palma M; Gregianin M; Fiduccia P; Evangelista L; Cervino AR; Saladini G; Borgato L; Nicoletto MO; Zagonel V
Crit Rev Oncol Hematol; 2012 Jul; 83(1):84-98. PubMed ID: 22245509
[TBL] [Abstract][Full Text] [Related]
11. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
12. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
13. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
15. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
